
How a new Action Plan is putting the Baltics on the biotech map
Combining cutting-edge science with agile policy, Lithuania, Latvia and Estonia are coming together to create the Baltic Biotech Hub. DDW’s Diana… Read More

Combining cutting-edge science with agile policy, Lithuania, Latvia and Estonia are coming together to create the Baltic Biotech Hub. DDW’s Diana… Read More

This ebook, sponsored by NuAire, explores the latest lab automation technologies and the ways they can create wide-reaching improvements to drug development projects. Not only can these systems help speed up the discovery and development process, but they also boost accuracy, cut costs, free up time for staff… Read More

“How AI is transforming drug discovery” is an exclusive guide published by DDW that examines the challenges and opportunities this technology is presenting throughout the industry. It features stories on how AI is shaping drug discovery, how RNA-targeted drug discovery is being pioneered by AI and how the technology… Read More

As long-term, targeted and sustainable weight loss become the main focus for the obesity drug market, Diana Turner asks whether GLP-1 receptor agonists like semaglutide and tirzepatide can maintain their dominance. With obesity on the rise and a significant area of investment for the big pharma companies,… Read More

How will preclinical discovery and clinical trials change in the coming year? And what role will regulators play? Diana Turner asks industry leaders for their predictions for 2026. A number of innovations are predicted to influence R&D in 2026, in both preclinical and clinical trials, including… Read More

Which drug modalities will dominate the market, and which global regions will be most influential? Diana Turner asks industry leaders for their predictions for 2026. The opportunities and challenges facing biotech and biopharma in 2026 are concisely summarised by Dr Kevin Land, Executive Medical Director Biotherapies… Read More

This ebook, sponsored by NuAire, explores the latest lab automation technologies and the ways they can create wide-reaching improvements to drug development projects.

This ebook, sponsored by NuAire, explores the latest lab automation technologies and the ways they can create wide-reaching improvements to drug development projects. Not only can these systems help speed up the discovery and development process, but they also boost accuracy, cut costs, free up time for staff… Read More

What does the coming year hold for advanced therapies? Diana Turner asks industry leaders for their predictions for 2026. 2025 was a mixed year for cell and gene therapies (CGT) with some incredible breakthroughs, but also a withdrawal of many companies from their cell therapy programmes. Read More

How big a role will AI play in the coming year? Diana Turner asks industry leaders for their predictions. As with all sectors, the role of artificial intelligence (AI) in drug discovery is expected to significantly increase in 2026 and beyond. Richard Young, CSO… Read More

Key highlights: Comprehensive explanation of the newly revised USP General Chapters 41 and 1251 Practical advice on how to implement these revised requirements effectively Guidance to help ensure compliance with updated USP weighing standards Download now. Read More

This imaging protocol handbook will help you accelerate your research by helping you plan and execute your imaging experiments. The guide covers main procedural steps to achieve your best results. Plan and optimise imaging experiments with clear, step-by-step procedural guidance. Master core and advanced techniques—from cell proliferation and… Read More

Advances in artificial intelligence and synthetic biology are driving a new frontier in genomic research. Megan Thomas explores what the future of genomics will look like. New technologies for the future In a Eureka! podcast interview with McKinsey, Howard Jacob, Vice President of Genomics Research… Read More

Advances in biospecimen science are resolving long-standing challenges that have historically hindered research quality, reproducibility, and innovation across drug discovery, translational medicine, and biobanking. These gaps limit scientific progress because even the most sophisticated analytical tools depend on high-quality, well-characterised human biological specimens. This custom eBook from BioIVT explores the… Read More

Megan Thomas provides overview of the global market for genomics, covering its rapid reshaping of drug discovery and development to offer faster, more precise, and cost-effective pathways to new therapies while driving global collaboration and innovation. Past to present As far back as 2000, academic experts… Read More

OTR Therapeutics has emerged from stealth and announced the successful completion of a $100 million Series A financing. The round was backed by True Light Capital, a wholly-owned subsidiary of Temasek, LAV, Pfizer Ventures, and Sirona Capital. Founded in March 2025, Shanghai-based OTR Therapeutics… Read More